Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Significant Blood Sugar Improvement With Xultophy(R) Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications 2018-06-25 20:05
Top 50 In Global Pharma By 2025 -- Luye Pharma Group Announces "Whole Value Chain" Global Collaboration Strategy 2018-06-25 13:35
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership 2018-06-25 07:55
Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study 2018-06-23 22:12
Ozempic® Provided Greater Weight Reductions for Adults With a Baseline BMI ≥25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis 2018-06-23 22:09
Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial 2018-06-23 22:06
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma 2018-06-22 08:07
Oracle Health Sciences Earns Frost & Sullivan's Enabling Technology Leadership Award for its eClinical Platform, Clinical One 2018-06-21 21:00
Prosten Health Holdings Limited officially renamed as "China Brilliant Global Limited" 2018-06-21 13:27
TOT BIOPHARM's 16,000L-capacity monoclonal antibodies production base put into operation 2018-06-21 10:40
Frost & Sullivan 2018 Award for Innovation in Artificial Intelligence for Aging Research and Drug Development 2018-06-20 22:41
CStone enrolls first patient in Phase I study for MEK inhibitor CS3006 in Australia 2018-06-20 19:07
Merck and Alibaba Health Announce Collaboration to Develop Patient-Centric Digital Services in China 2018-06-20 15:15
TUV Rheinland launches first Radiological Health and Safety Convention 2018-06-20 08:00
Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials 2018-06-19 21:52
China Biologic Announces Receipt of Non-Binding Acquisition Proposal 2018-06-19 20:00
Kazia Releases Preliminary Cantrixil Phase I Data 2018-06-19 18:00
Alpha Biopharma Announces Series A Financing 2018-06-19 17:36
NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics 2018-06-19 04:39
SOPHiA GENETICS Acquires Interactive Biosoftware to Drive Growth and Accelerate Data-Driven Medicine Adoption Around the World 2018-06-16 14:00
1 355 356 357 358 359 412